Mobile Cognitive Behavioral Therapy for Medical and Graduate Students
- Conditions
- Anxiety DisordersDepression
- Interventions
- Behavioral: Clinician Delivered CBTBehavioral: Supplemental MAYA App
- Registration Number
- NCT05823922
- Lead Sponsor
- Weill Medical College of Cornell University
- Brief Summary
The study aims to assess and compare clinician-delivered cognitive behavior therapy (CBT) supplemented with "MAYA", a mobile cognitive behavioral therapy app program to clinician-delivered cognitive behavioral therapy alone. The experimental group will be asked to use the mobile application at least two times per week for six weeks, for at least 20 minutes on each of the two days in addition to the clinician-delivered CBT. Participants will complete a weekly self-report assessment battery designed to assess anxiety and mood symptoms. The investigators think that clinician-delivered CBT supplemented with "MAYA" will improve more effective at improving symptoms of anxiety and depression than clinician-delivered CBT alone.
- Detailed Description
Growing evidence suggests a need for anxiety and depression treatments that can be disseminated easily to young adults. Many do not seek out treatment for reasons including lack of availability and high cost. There is a growing need for accessible, affordable, research-supported treatments designed to increase the practice of skills and therefore improve treatment outcomes. Graduate students use mobile devices frequently; thus, mobile app-based interventions may be particularly appealing to individuals in this age range with anxiety or depression who are unable to access more traditional psychotherapy administered in person by a therapist.
The study aims to compare the efficacy and feasibility of clinician-delivered cognitive behavior therapy supplemented with the mobile app program to clinician- delivered cognitive behavioral therapy alone. Young adults with anxiety and/or depression will be randomized to clinician-delivered CBT (active control group) or to the clinician CBT + mobile app (intervention group). In the active control group, participants will participate in weekly clinician-delivered Cognitive Behavior Therapy. In the intervention group, participants will participate in weekly clinician-delivered Cognitive Behavior Therapy and use a mobile application for at least 20 minutes two times per week for six weeks.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Age between 18 and 40 years.
- Clinically significant anxiety (as determined by a score of 10 or greater on the GAD-7) or clinically significant depression (as determined by a score of 10 or greater on the PHQ-9).
- Current graduate student at Weill Cornell Medicine.
- Access to an Apple iPhone
- Lifetime diagnosis of a bipolar or psychotic disorder.
- Intent or plan to attempt suicide.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Clinician-delivered Cognitive Behavioral Therapy only Clinician Delivered CBT Participants receive treatment with a licensed clinician for 6 weeks. Clinician-delivered CBT + Supplemental app Clinician Delivered CBT Mobile application at least two times per week for six weeks, for at least 20 minutes on each of the two days in addition to the clinician-delivered CBT Clinician-delivered CBT + Supplemental app Supplemental MAYA App Mobile application at least two times per week for six weeks, for at least 20 minutes on each of the two days in addition to the clinician-delivered CBT
- Primary Outcome Measures
Name Time Method Change in depressive symptoms from baseline to end of treatment as measured by the PHQ-9 Baseline to endpoint [Week 6] The primary symptom measure for depression will be the Patient Health Questionnaire 9-item measure (PHQ-9). The PHQ-9 is a 9-item self-report questionnaire measure of the severity of depression symptoms. Scores range from 0 to 27, where higher scores indicate a greater severity of symptoms, and lower scores indicate mild to no depression symptoms.
Change in anxiety symptoms from baseline to end of treatment as measured by the GAD-7. Baseline to endpoint [Week 6] The primary symptom measure for anxiety will be the Generalized Anxiety Disorder 7-item scale. The GAD-7 is a 7-item self-report questionnaire measure of the severity of generalized anxiety symptoms. Scores range from 0 to 27 where higher scores indicate a greater severity of symptoms, and lower scores indicate mild to no anxiety symptoms.
- Secondary Outcome Measures
Name Time Method Adherence as measured by the mean difference in total number of completed clinician assigned homework between groups Endpoint [Week 6] Retention as measured by the mean difference in total number of completed study weeks between groups Endpoint [Week 6]
Trial Locations
- Locations (1)
Weill Cornell Medical College
🇺🇸New York, New York, United States